Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: Utilization of a more suitable medium for in-vitro dissolution study

Journal of Controlled Release

Volumn 119, Issue 2, 2007, Pages 222-228

  Fujioka, Yoshitsugu ^a   Kadono, Keitaro ^a   Fujie, Yasuko ^a   Metsugi, Yukiko ^a   Ogawara, Ken ichi ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Biopharmaceutics classification system class II; In vitro dissolution study; Oral absorption; Powder; Prediction

Indexed keywords

ABSORPTION; COMPUTER SIMULATION; DISSOLUTION; KINETICS; MATHEMATICAL MODELS;

BIOPHARMACEUTICS CLASSIFICATION SYSTEM CLASS II; IN-VITRO DISSOLUTION STUDY; ORAL ABSORPTION;

DRUG PRODUCTS;

GRISEOFULVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG SOLUBILITY; GASTROINTESTINAL TRANSIT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POWDER; PREDICTION; PRIORITY JOURNAL; RAT; SIMULATION;

ADMINISTRATION, ORAL; ANIMALS; GASTROINTESTINAL TRANSIT; GRISEOFULVIN; INTESTINAL ABSORPTION; MALE; MODELS, ANIMAL; MODELS, CHEMICAL; POWDERS; PREDICTIVE VALUE OF TESTS; RATS; RATS, WISTAR; SOLUBILITY;

EID: 34248582287     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.03.002     Document Type: Article

References (35)

1. Porter C.J.H., and Charman W.N. In vitro assessment of oral lipid based formulation. Adv. Drug Deliv. Rev. 50 Suppl. 1 (2001) S127-S147
2. Doo-Man O., Curl R.L., and Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in human: a mathematical model. Pharm. Res. 10 (1993) 264-270
3. Yamashita K., Nakate T., Okimoto K., Ohiki A., Tokunaga Y., Ibuki R., Higaki K., and Kimura T. Establishment of new preparation method of solid dispersion formulation of tacrolimus. Int. J. Pharm. 267 (2003) 79-91
4. Jinno J., Kamada N., Miyake M., Yamada K., Mukai T., Odomi M., Toguchi H., Liversidge G.G., Higaki K., and Kimura T. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release 111 (2006) 56-64
5. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
6. Endo Y., Hanada K., Miyake M., Ogawara K., Higaki K., and Kimura T. Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium. J. Pharm. Sci. 91 (2002) 730-743
7. Miyake M., Minami T., Hirota M., Toguchi H., Odomi M., Ogawara K., Higaki K., and Kimura T. Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids. J. Control. Release 111 (2006) 27-34
8. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
9. Yu L.X., Amidon G.L., Polli J.E., Zhao H., Mehta M.U., Conner D.P., Shah V.P., Lesko L.J., Chen M.-L., Lee V.H.L., and Hussain A.S. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19 (2002) 921-925
10. Lindenberg M., Kopp S., and Dressman J.B. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58 (2004) 265-278
11. Galia E., Nicolaides E., Horter D., Lobenberg R., Reppas C., and Dressman J.B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15 (1998) 698-705
12. Dressman J.B., and Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S73-S80
13. Clements J.A., Heading R.C., Nimmo W.S., and Preseott L.F. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 24 (1978) 420-431
14. Gramatte T. Griseofulvin absorption from different sites in the human small intestine. Biopharm. Drug Dispos. 15 (1994) 747-759
15. Sawamoto T., Haruta S., Kurosaki Y., Higaki K., and Kimura T. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J. Pharm. Pharmacol. 49 (1997) 450-457
16. Haruta S., Iwasaki N., Ogawara K., Higaki K., and Kimura T. Absorption behavior of orally administered drugs in rats treated with propantheline. J. Pharm. Sci. 87 (1998) 1081-1085
17. Kimura T., Iwasaki N., Yokoe J., Haruta S., Yokoo Y., Ogawara K., and Higaki K. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model. Drug Metab. Dispos. 28 (2000) 577-581
18. Kimura T., and Higaki K. Gastrointestinal transit and drug absorption. Biol. Pharm. Bull. 25 (2002) 149-164
19. Yokoe J., Iwasaki N., Haruta S., Kadono K., Ogawara K., Higaki K., and Kimura T. Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. J. Control. Release 86 (2003) 305-313
20. Haruta S., Kawai K., Jinnouchi S., Ogawara K., Higaki K., Tamura S., Arimori K., and Kimura T. Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy. J. Pharm. Sci. 90 (2001) 464-473
21. Haruta S., Kawai K., Nishii R., Jinnouchi S., Ogawara K., Higaki K., Tamura S., Arimori K., and Kimura T. Prediction plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers. Int. J. Pharm. 233 (2002) 179-190
22. Kadono K., Yokoe J., Ogawara K., Higaki K., and Kimura T. Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (GITA) model. Drug Metab. Pharmacokinet. 17 (2002) 307-315
23. Schanker L.S., Shore P.A., Brodie B.B., and Hogben C.A.M. Absorption of drugs from the stomach. I. The rat. J. Pharmacol. Exp. Ther. 120 (1957) 528-539
24. Kakemi K., Sezaki H., Konishi R., Kimura T., and Okita A. Effect of bile salts on the gastrointestinal absorption of drugs. II. Mechanism of the enhancement of the intestinal absorption of sulfaguanidine by bile salts. Chem. Pharm. Bull. 18 (1970) 1034-1039
25. Stella V.J., Martodihardio S., Terada K., and Rao V.M. Some relation ships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications. J. Pharm. Sci. 87 (1998) 1235-1241
26. Stella V.J., Martodihardio S., and Rao V.M. Aqueous solubility and dissolution rate dose not adequately predict in vivo performance: a probe utilizing some N-acylixymethyl phenytoin prodrugs. J. Pharm. Sci. 88 (1998) 775-779
27. Yamaoka K., and Tanigawara Y. Deconvolution. Introduction to Pharmacokinetic Analysis by Microcomputer (1984) 91-112
28. Rowland M., Riegelman S., and Epstein W.L. Absorption kinetics of griseofulvin in man. J. Pharm. Sci. 57 (1968) 984-989
29. Hägermark Ö., Berlin A., Wallin I., and Boréus O.L. Plasma concentrations of griseofulvin in healthy volunteers and out-patients treated for onychomycosis. Acta Dermatovenerol. 56 (1976) 289-296
30. Chen M.-L., Lam G., Lee M.G., and Chiou W.L. Arterial and venous blood sampling in pharmacokinetic studies: griseofulvin. J. Pharm. Sci. 71 (1982) 1386-1389
31. Chiou W.L., and Riegelman S. Absorption characteristics of solid dispersed and micronized griseofulvin in man. J. Pharm. Sci. 60 (1971) 1376-1380
32. Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Tamaki N., Kamimura H., Katougi Y., and Omi Y. Bioavailability of griseofulvin from tablets in beagle dogs and correlation rate and bioavailability in humans. J. Pharm. Sci. 71 (1982) 1169-1173
33. Grisafe J.A., and Hayton W.L. Intestinal absorption of griseofulvin from a triolein digestion mixture in rats. J. Pharm. Sci. 67 (1978) 895-899
34. Levy G., Leeonards J.R., and Prockual J.A. Development of in vitro dissolution tests witch correlate quantitatively with dissolution rate-limited drug absorption in man. J. Pharm. Sci. 54 (1965) 1719-1722
35. Gibaldi M., and Feldman S. Establishment of sink conditions in dissolution rate determinations: Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 56 (1967) 1238-1242